Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Boston Therapeutics initiates Phase IIb study of Sugardown
Boston Therapeutics initiates Phase IIb study of Sugardown
Boston Therapeutics initiates Phase IIb study of Sugardown
Submitted by
admin
on May 29, 2014 - 8:54am
Source:
The Fly on the Wall
News Tags:
Boston Therapeutics
Sugardown
diabetes
Headline:
Boston Therapeutics initiates Phase IIb study of Sugardown
Do Not Allow Advertisers to Use My Personal information
